Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More

São Paulo, Brazil – November 2nd 2017.
At the occasion of the World Hepatitis Summit, a large coalition of patients, clinicians, social workers, representatives of the drug using community, researchers, and public health experts express their whole-hearted support to the commitment of the World (...) More

Petition to stop Gilead’s anti-diversion program that violates physician and patient rights to protect its profit. More

13-15 May 2019, Tbilisi, Georgia
The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More

1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More

In July 2017, 37 treatment activists from 17 countries—including 14 low- and middle-income countries (LMICs)—met with representatives from three generics and three diagnostics companies. This Hepatitis C World Community Advisory Board meeting was an opportunity for activists to present demands (...) More